Research Article
Effect of Different Blood-Pressure-Lowering Regimens on the Blood Pressure Control among Hypertensive Patients Treated in Hospital Conditions
Table 4
Hypertensive drugs used by the patients admitted to the hospital due to hypertension (n = 204).
| Hypertensive drugs group | Active substance | Percentage of patients receiving the drug (%) |
| Angiotensin-converting enzyme inhibitors (ACEI) | Overall | 61.27 | Ramipril | 25.98 | Captopril | 19.11 | Perindopril | 7.84 | Verapamil | 2.45 | Chinapril | 5.88 |
| β-Blockers | Overall | 69.30 | Bisoprolol | 28.92 | Carvedilol | 16.17 | Nebivolol | 16.17 | Metoprolol | 8.33 |
| Diuretics | Overall | 87.75 | Indapamid | 26.47 | Furosemid | 5.39 | Torasemid | 38.23 | Spironolactone | 17.64 |
| Calcium channel antagonist | Overall | 53.43 | Amlodipine | 45.58 | Lercanidipine | 7.84 |
| Angiotensin II receptor antagonists (ARBs) | Overall | 30.88 | Valsartan | 17.64 | Telmisartan | 5.39 | Losartan | 6.37 | Candesartan | 1.47 |
| α-Adrenolytics | Overall | 28.43 | Doxasosin | 23.52 | Clonidine | 4.90 |
| Fixed-dose combination drug | Overall | 5.39 | Perindopril + amlodipine | 2.45 | Valsartan + amlodipine | 1.96 | Ramipril + amlodipine | 0.98 |
|
|